APA

Goodlad R. A., Ryan A. J., Wedge S. R., Pyrah I. T., Alferez D., Poulsom R., Smith N. R., Mandir N., Watkins A. J. & Wilkinson R. W. (20061113). Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer. : Carcinogenesis.

Chicago

Goodlad R A, Ryan A J, Wedge S R, Pyrah I T, Alferez D, Poulsom R, Smith N R, Mandir N, Watkins A J and Wilkinson R W. 20061113. Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer. : Carcinogenesis.

Harvard

Goodlad R. A., Ryan A. J., Wedge S. R., Pyrah I. T., Alferez D., Poulsom R., Smith N. R., Mandir N., Watkins A. J. and Wilkinson R. W. (20061113). Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer. : Carcinogenesis.

MLA

Goodlad R A, Ryan A J, Wedge S R, Pyrah I T, Alferez D, Poulsom R, Smith N R, Mandir N, Watkins A J and Wilkinson R W. Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer. : Carcinogenesis. 20061113.